These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17079285)

  • 1. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
    Thio CL; Astemborski J; Bashirova A; Mosbruger T; Greer S; Witt MD; Goedert JJ; Hilgartner M; Majeske A; O'Brien SJ; Thomas DL; Carrington M
    J Virol; 2007 Jan; 81(2):441-5. PubMed ID: 17079285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerns related to CCR5 gene delta 32 mutation role in hepatitis B virus infection.
    Drozd-Dąbrowska M; Gańczak M; Karpińska E
    Przegl Epidemiol; 2017; 71(4):571-581. PubMed ID: 29415549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China.
    Zhang C; He Y; Shan KR; Tan K; Zhang T; Wang CJ; Guan ZZ
    J Int Med Res; 2018 Feb; 46(2):739-751. PubMed ID: 29239247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CCR5 (CCR5Δ32) and TLR3 (RS5743313) gene polymorphisms prevent chronic hepatitis B infection?
    Tuncel B; Kaygusuz S; Sayın Kocakap DB; Aksoy E; Azkur AK
    J Med Virol; 2023 Jan; 95(1):e28376. PubMed ID: 36478230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
    Thio CL; Astemborski J; Thomas R; Mosbruger T; Witt MD; Goedert JJ; Hoots K; Winkler C; Thomas DL; Carrington M
    J Immunol; 2008 Dec; 181(11):7944-7. PubMed ID: 19017985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population.
    Akgöllü E; Bilgin R; Akkız H; Ülger Y; Kaya BY; Karaoğullarından Ü; Arslan YK
    Virus Res; 2017 Mar; 232():6-12. PubMed ID: 28119119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
    Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH
    J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients.
    Abdolmohammadi R; Shahbazi Azar S; Khosravi A; Shahbazi M
    Asian Pac J Cancer Prev; 2016 Oct; 17(10):4643-4646. PubMed ID: 27892677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.
    Suneetha PV; Sarin SK; Goyal A; Kumar GT; Shukla DK; Hissar S
    J Hepatol; 2006 May; 44(5):856-63. PubMed ID: 16545485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
    Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
    Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.
    El-Moamly AA; El-Sweify MA; Rashad RM; Abdalla EM; Ragheb MM; Awad MM
    Parasitol Res; 2013 Jul; 112(7):2745-52. PubMed ID: 23515570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infection.
    Khorramdelazad H; Hakimizadeh E; Hassanshahi G; Rezayati M; Sendi H; Arababadi MK
    J Med Virol; 2013 Jun; 85(6):964-8. PubMed ID: 23588722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 plays important roles in hepatitis B infection.
    Sanchooli J; Sanadgol N; Kazemi Arababadi M; Kennedy D
    Viral Immunol; 2014 Feb; 27(1):2-6. PubMed ID: 24405101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of human leukocyte antigen DP/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations.
    Xiang X; Guo Y; Yang L; Ge Q; Mijit S; Xu F
    Infect Genet Evol; 2016 Sep; 43():407-11. PubMed ID: 27291710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.